Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

News Conference News ESC Heart Failure 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

May 20, 2025

Cardiology Consults Tied to Better Outcomes in Patients With HF

News Conference News ESC Heart Failure 2025

Cardiology Consults Tied to Better Outcomes in Patients With HF

May 19, 2025

Remote Monitoring in Real-world HF Cuts All-Cause Mortality TELESAT-HF

News Conference News ESC Heart Failure 2024

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

Michael O'Riordan

May 12, 2024

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

News Conference News ESC Heart Failure 2023

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

June 01, 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

News Conference News ESC Heart Failure 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

May 25, 2023

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

News Conference News ESC Heart Failure 2023

ENACT-HF: Natriuresis-Guided Diuretic Protocol Beats Usual Care

May 25, 2023

Loop Diuretics Are Heavily Prescribed Outside of HF: That’s a Problem

News Conference News ESC Heart Failure 2023

Loop Diuretics Are Heavily Prescribed Outside of HF: That’s a Problem

May 23, 2023

Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial

News Conference News ESC Heart Failure 2023

Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial

May 23, 2023

More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF

News Conference News ESC Heart Failure 2023

More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF

May 22, 2023

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

News Conference News ESC Heart Failure 2023

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

May 21, 2023

Aficamten Safe, Effective for Up to 6 months in Obstructive HCM: REDWOOD-HCM OLE

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

May 31, 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

May 26, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

May 25, 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

May 23, 2022

Dapagliflozin Boosts Health Status Across LVEF Range

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

May 23, 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

News Conference News ESC Heart Failure 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

May 22, 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

May 22, 2022

Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR

News Conference News ESC Heart Failure 2021

Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR

July 06, 2021

IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients

News Conference News ESC Heart Failure 2021

IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients

June 30, 2021

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

May 30, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.